Provider review
Regenics review
Names the standing rate beside its introductory one, then charges medication on top of both.
The membership half of the bill is fully knowable in advance. The medication half has no figure anywhere.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Regenics
$39/mo first month then $79/mo, + medication cost
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is a membership business and it is unusually straight about the membership half. Two numbers are printed rather than one: what you pay to join and what you pay from month two, with the relationship between them stated in plain words instead of an asterisk pointing nowhere. That is better disclosure than most intro-rate sellers manage, and it means you can work out the annual cost of belonging before signing anything. The half that is missing is the one that matters more. Medication is charged on top and no figure for it appears anywhere on the site, for either molecule, branded or compounded. So you can compute exactly the smaller part of your bill and nothing at all of the larger part, which is the wrong way round and makes the published figures unusable against a seller quoting one all-in number. What the membership buys is real enough — clinician oversight, titration support, and access to a wider catalog of peptides and hormone therapy on the same account — and if you already intend to run several protocols, the shared overhead is an argument. If your only question is what a low dose of a GLP-1 costs, the site answers a different question thoroughly and that one not at all.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want several protocols under one membership rather than a single-product seller
- You want the standing rate stated up front rather than discovered in month two
- You want both branded and compounded options available from the same clinician
Look elsewhere if
- You are comparing all-in monthly prices. Medication here is charged on top
- You want the medication costed before you join. No figure for it is published
- You are only after a GLP-1 and have no use for the wider catalog
What it actually costs
Price as published
The published figure is a membership and the medication is extra: "$39/mo + medication cost" · ★★ the footnote is the kind most sellers omit — "the $39 promotion applies to your first month only for new customers. After that, the standard rate is $79 per month" — so both the introductory rate AND the rate it becomes are printed, which makes the membership side of the bill fully knowable in advance · the medication side is not: no figure appears for either molecule anywhere · semaglutide and tirzepatide are both named with their own entry points, and the catalog also covers peptides, testosterone therapy and NAD+ under the same membership · both brand-name and compounded GLP-1 medications are offered, with provider-led protocols, dose titration and ongoing support described · no dose is published
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The published figure is a MEMBERSHIP with medication charged on top, and no medication figure appears anywhere for either molecule, branded or compounded. ★★ The membership half is disclosed better than most: both the introductory rate and the standing rate it becomes are printed, with the switch explained in plain words rather than left to an asterisk — so the smaller part of the bill is fully knowable and the larger part is not, which is the wrong way round for a price comparison. Both molecules are named and the same membership covers peptides, hormone therapy and NAD+. No low-dose product and no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both the introductory and the standing membership rate are printed, with the switch explained.
- Both molecules are named, in branded and compounded form, with titration support described.
- One membership covers peptides, hormone therapy and NAD+ alongside the GLP-1 line.
Pharmacy, labs and oversight
Regenics does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Regenics publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
This is a membership business and it is unusually straight about the membership half. Two numbers are printed rather than one: what you pay to join and what you pay from month two, with the relationship between them stated in plain words instead of an asterisk pointing nowhere. That is better disclosure than most of the intro-rate sellers here manage, and it means a reader can work out the annual cost of belonging before they sign anything. The half that is missing is the one that matters more. Medication is charged on top and no figure for it appears anywhere on the site, for either molecule, branded or compounded. So a reader can compute exactly the smaller part of their bill and nothing at all of the larger part, which is the wrong way round and makes the published figures unusable as a comparison against a seller quoting one all-in number. What the membership buys is real enough — clinician oversight, titration support and access to a wider catalog of peptides and hormone therapy on the same account — and for someone already intending to run several protocols the shared overhead is an argument. For someone whose only question is what a low dose of a GLP-1 costs, the site answers a different question thoroughly and that one not at all.
The honest cons
Medication is charged on top of the membership and carries no published figure.
- The cheaper of the two membership figures applies to the first month only.
- No dose is published, so nothing can be matched to an amount of drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Regenics is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#255 of 373
Ordered with the companies that pay us first, and Regenics is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.